Literature DB >> 18333179

Resistant pathogens in biliary obstruction: importance of cultures to guide antibiotic therapy.

Michael J Englesbe1, Lillian G Dawes.   

Abstract

BACKGROUND: Cholangitis, infection of the bile ducts, is a serious condition that necessitates prompt and efficacious treatment for a good clinical outcome. A single center retrospective study of cholangitis was conducted to better define the spectrum of responsible pathogens and their antibiotic sensitivities.
METHODS: We studied all patients at our hospital who had cholangitis from January 1998 to June 2004. Patients were identified by ICD-9 codes and the cause of the cholangitis, the treatment and culture data were noted by review of the medical record.
RESULTS: Thirty patients presented with cholangitis as noted by the clinical symptoms of jaundice, fever and abdominal pain. The cause of the biliary obstruction was gallstones in 18 patients, benign biliary strictures in 5 and malignant obstruction in 7. All the patients with malignant obstruction with cholangitis had stents; there were no cases of cholangitis in malignant obstruction unless prior instrumentation had been performed. The most common isolates were Enterococcus>E. coli>Enterobacter>Klebsiella. Sixty-four percent of blood cultures and all but one of the bile cultures grew organisms. Seventy-two percent of patients had positive blood cultures with at least one resistant organism present and 36% had organisms resistant to multiple antibiotics. Fifty percent of patients with benign biliary disease and positive blood cultures had multiple organisms growing in their blood. Three-quarters of the isolates were resistant to one or more antibiotics and one-quarter of isolates were resistant to three or more antibiotics. Resistant organisms were found regardless of the cause of the biliary obstruction. DISCUSSION: For all causes of cholangitis, there is a high incidence of positive blood cultures and a high rate of antibiotic resistance. For optimal treatment, blood and/or bile cultures should be routinely performed to optimize antibiotic therapy.

Entities:  

Year:  2005        PMID: 18333179      PMCID: PMC2023940          DOI: 10.1080/13651820510028792

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  22 in total

1.  Bacteriology of the gallbladder bile in normal subjects.

Authors:  A Csendes; M Fernandez; P Uribe
Journal:  Am J Surg       Date:  1975-06       Impact factor: 2.565

2.  Gangrenous cholecystitis: analysis of risk factors and experience with laparoscopic cholecystectomy.

Authors:  L T Merriam; S A Kanaan; L G Dawes; P Angelos; J B Prystowsky; R V Rege; R J Joehl
Journal:  Surgery       Date:  1999-10       Impact factor: 3.982

3.  Duration of antibiotic therapy for cholangitis after successful endoscopic drainage of the biliary tract.

Authors:  Anja U G van Lent; Joep F W M Bartelsman; Guido N J Tytgat; Peter Speelman; Jan M Prins
Journal:  Gastrointest Endosc       Date:  2002-04       Impact factor: 9.427

Review 4.  Surgical treatment of biliary tract infections.

Authors:  K D Lillemoe
Journal:  Am Surg       Date:  2000-02       Impact factor: 0.688

5.  Endoscopic management of occluded biliary Wallstents: a cancer center experience.

Authors:  Jack Thomas Bueno; Hans Gerdes; Robert C Kurtz
Journal:  Gastrointest Endosc       Date:  2003-12       Impact factor: 9.427

6.  Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis.

Authors:  Rungsun Rerknimitr; Evan L Fogel; Cem Kalayci; Edward Esber; Glen A Lehman; Stuart Sherman
Journal:  Gastrointest Endosc       Date:  2002-12       Impact factor: 9.427

Review 7.  Management of cholangitis.

Authors:  Philippus C Bornman; Johan I van Beljon; Jake E J Krige
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

8.  Endoscopic sphincterotomy and biliary drainage in patients with cholangitis due to common bile duct stones.

Authors:  J Boender; G A Nix; M A de Ridder; J Dees; H E Schütte; H R van Buuren; M van Blankenstein
Journal:  Am J Gastroenterol       Date:  1995-02       Impact factor: 10.864

Review 9.  Acute cholangitis.

Authors:  Pamela A Lipsett; Henry A Pitt
Journal:  Front Biosci       Date:  2003-09-01

10.  Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitis.

Authors:  W B Gerecht; N K Henry; W W Hoffman; S M Muller; N F LaRusso; J E Rosenblatt; W R Wilson
Journal:  Arch Intern Med       Date:  1989-06
View more
  9 in total

Review 1.  The Great ESKAPE: Exploring the Crossroads of Bile and Antibiotic Resistance in Bacterial Pathogens.

Authors:  Kevin S Gipson; Kourtney P Nickerson; Eliana Drenkard; Alejandro Llanos-Chea; Snaha Krishna Dogiparthi; Bernard B Lanter; Rhianna M Hibbler; Lael M Yonker; Bryan P Hurley; Christina S Faherty
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

2.  Differences in bile microbiology according to region and hospital: response to correspondence on "Bile microbiology at a hospital in southern Taiwan".

Authors:  W Kwon; S-W Kim; J-Y Jang
Journal:  Infection       Date:  2013-02-10       Impact factor: 3.553

3.  Evaluation of Biliary Bacterial Resistance in Patients with Frequent Biliary Instrumentation, One Size Does Not Fit All.

Authors:  Maen Masadeh; Subhash Chandra; Daniel Livorsi; Frederick Johlin; William Silverman
Journal:  Dig Dis Sci       Date:  2018-08-28       Impact factor: 3.199

4.  Association of diverse bacterial communities in human bile samples with biliary tract disorders: a survey using culture and polymerase chain reaction-denaturing gradient gel electrophoresis methods.

Authors:  E Tajeddin; S J Sherafat; M R S Majidi; M Alebouyeh; A H M Alizadeh; M R Zali
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-18       Impact factor: 3.267

5.  Changing trend in bile microbiology and antibiotic susceptibilities: over 12 years of experience.

Authors:  W Kwon; J-Y Jang; E-C Kim; J W Park; I W Han; M J Kang; S-W Kim
Journal:  Infection       Date:  2012-11-21       Impact factor: 3.553

6.  Phylogeny, Resistome, and Virulome of Escherichia coli Causing Biliary Tract Infections.

Authors:  Ángel Rodríguez-Villodres; Rémy A Bonnin; José Manuel Ortiz de la Rosa; Rocío Álvarez-Marín; Thierry Naas; Javier Aznar; Jerónimo Pachón; José Antonio Lepe; Younes Smani
Journal:  J Clin Med       Date:  2019-12-02       Impact factor: 4.241

7.  Extended Spectrum-β-Lactamase or Carbapenemase Producing Bacteria Isolated from Patients with Acute Cholangitis.

Authors:  Ja Chung Goo; Mun Hyuk Seong; Young Kwang Shim; Hee Seung Lee; Joung-Ho Han; Jung-Ho Han; Kyeong Seob Shin; Jae-Woon Choi; Sei Jin Youn; Seon Mee Park
Journal:  Clin Endosc       Date:  2012-06-30

8.  Risk factors of post endoscopic retrograde cholangiopancreatography bacteremia.

Authors:  Min-Sun Kwak; Eun Sun Jang; Ji Kon Ryu; Yong-Tae Kim; Yong Bum Yoon; Joo Kyung Park
Journal:  Gut Liver       Date:  2012-11-13       Impact factor: 4.519

9.  A Patient Presenting with Cholangitis due to Stenotrophomonas Maltophilia and Pseudomonas Aeruginosa Successfully Treated with Intrabiliary Colistine.

Authors:  Pablo N Pérez; María A Ramírez; José A Fernández; Laura Ladrón de Guevara
Journal:  Infect Dis Rep       Date:  2014-05-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.